“Excellent outcomes” for Zilver Vena® venous stent sustained out to three years in challenging patient groups

8880

This advertorial is sponsored by Cook Medical.

The Zilver Vena venous self-expanding stent system (Cook Medical) is associated with high rates of patency by ultrasound, freedom from clinically-driven reintervention and clinical improvement among various challenging subgroups, according to newly released three-year subset data from the VIVO clinical study. In this advertorial for Venous News, Anthony Comerota (Inova Heart and Vascular Institute, Inova Alexandria Hospital, Alexandria, USA) and Paul Gagne (Vascular Care Connecticut, Darien, USA) discuss these latest findings. 


LEAVE A REPLY

Please enter your comment!
Please enter your name here